About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Prnp-SNCA*A53T)AAub
transgene insertion A, Georg Auburger
MGI:3723258
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Pink1tm1Aub/Pink1tm1Aub
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
involves: 129S/SvEv * FVB/N MGI:5604250
cx2
Sncatm1Nbm/Sncatm1Nbm
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
involves: 129S6/SvEvTac * FVB/N MGI:3723312
tg3
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub involves: 129S6/SvEvTac * FVB/N MGI:3723310
tg4
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub involves: FVB/N MGI:3723272
tg5
Tg(Prnp-SNCA*A53T)AAub/? involves: FVB/N MGI:5639272


Genotype
MGI:5604250
cx1
Allelic
Composition
Pink1tm1Aub/Pink1tm1Aub
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
Genetic
Background
involves: 129S/SvEv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pink1tm1Aub mutation (2 available); any Pink1 mutation (8 available)
Tg(Prnp-SNCA*A53T)AAub mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• reduction in vertical activity by 3 months of age (J:214065)
• reduction in vertical activity by 3 months of age (J:214065)
• reductions in horizontal activity by 3 months of age (J:214065)
• reductions in horizontal activity by 3 months of age (J:214065)
• 25% of mice exhibit progressive hindlimb paralysis at ages greater than 1 year (J:214065)
• 25% of mice exhibit progressive hindlimb paralysis at ages greater than 1 year (J:214065)
• 16/60 mice older than one year exhibit flaccid paresis of the hindlimbs, progressing to full paraplegia (J:214065)
• 16/60 mice older than one year exhibit flaccid paresis of the hindlimbs, progressing to full paraplegia (J:214065)
• reductions in stereotype movement counts by 3 months of age (J:214065)
• reductions in stereotype movement counts by 3 months of age (J:214065)

mortality/aging
• late onset increase in mortality rate at 450 days as compared to wild-type controls (J:214065)
• some mice develop a lethal motor deficit at greater than one year (J:214065)
• late onset increase in mortality rate at 450 days as compared to wild-type controls (J:214065)
• some mice develop a lethal motor deficit at greater than one year (J:214065)

nervous system
• protein aggregates with pSer129-SNCA, P62, and ubiquitin immunoreactivity appears as granular and thread-like in neuronal cytoplasm of neurons with extensions along neurites (J:214065)
• protein aggregates with pSer129-SNCA, P62, and ubiquitin immunoreactivity appears as granular and thread-like in neuronal cytoplasm of neurons with extensions along neurites (J:214065)
• some neurites exhibit corkscrew morphology (J:214065)
• some neurites exhibit corkscrew morphology (J:214065)
• protein aggregates with pSer129-SNCA, P62 and ubiquitin immunoreactivity are observed in grey matter of lumbar spinal cord of paralyzed animals aged to 15-17 months (J:214065)
• aggregate pathology is milder in thoracic and cervical spinal cord (J:214065)
• immunoreactivity appears as granular and thread-like in neuronal cytoplasm of neurons with extensions along neurites (J:214065)
• protein aggregates are observed in non-paralyzed animals, but with little neurite pathology (J:214065)
• discrete lesions are found in motor cortex, but not striatum of paralyzed mice (J:214065)
• minimal lesions are found in ventral tegmental area of non-paralytic mice (J:214065)
• aggregate formation is found in non-dopaminergic neurons (NeuN-positive) (J:214065)
• no aggregate formation is found in dopaminergic neurons (J:214065)
• protein aggregates with pSer129-SNCA, P62 and ubiquitin immunoreactivity are observed in grey matter of lumbar spinal cord of paralyzed animals aged to 15-17 months (J:214065)
• aggregate pathology is milder in thoracic and cervical spinal cord (J:214065)
• immunoreactivity appears as granular and thread-like in neuronal cytoplasm of neurons with extensions along neurites (J:214065)
• protein aggregates are observed in non-paralyzed animals, but with little neurite pathology (J:214065)
• discrete lesions are found in motor cortex, but not striatum of paralyzed mice (J:214065)
• minimal lesions are found in ventral tegmental area of non-paralytic mice (J:214065)
• aggregate formation is found in non-dopaminergic neurons (NeuN-positive) (J:214065)
• no aggregate formation is found in dopaminergic neurons (J:214065)

skeleton
• 3/60 mice older than one year exhibit kyphosis, falls and rigidity (J:214065)
• 3/60 mice older than one year exhibit kyphosis, falls and rigidity (J:214065)




Genotype
MGI:3723312
cx2
Allelic
Composition
Sncatm1Nbm/Sncatm1Nbm
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sncatm1Nbm mutation (5 available); any Snca mutation (15 available)
Tg(Prnp-SNCA*A53T)AAub mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no mutants survive past 23 months, whereas controls show 60% survival at 24 months of age; mortality is significantly higher than in SCNAtm1Nsb homozygotes or Tg(Prnp-SNCA*A53T)BAub homozygotes (J:124976)
• major cause of death is a late onset neuronopathy, with onset from 16 to 23 months (J:124976)
• no mutants survive past 23 months, whereas controls show 60% survival at 24 months of age; mortality is significantly higher than in SCNAtm1Nsb homozygotes or Tg(Prnp-SNCA*A53T)BAub homozygotes (J:124976)
• major cause of death is a late onset neuronopathy, with onset from 16 to 23 months (J:124976)

growth/size/body
• mice weigh same as controls at 12-13 months of age, but differ at 17-18 months (42.6 gm vs 48.5 g wt) and reach a weight plateau at this age whereas controls continue to gain weight to 2 years of age (J:124976)
• mice weigh same as controls at 12-13 months of age, but differ at 17-18 months (42.6 gm vs 48.5 g wt) and reach a weight plateau at this age whereas controls continue to gain weight to 2 years of age (J:124976)
• 12-20% loss in body weight is observed ~2 weeks prior to onset of motor dysfunction in limbs (J:124976)
• 12-20% loss in body weight is observed ~2 weeks prior to onset of motor dysfunction in limbs (J:124976)

behavior/neurological
• dysfunction in a single hindlimb is usually the first pathological sign (J:124976)
• dysfunction in a single hindlimb is usually the first pathological sign (J:124976)
• when suspended by the tail, mice do not show limb clasping, but limbs hang limply, and never are splayed as in wild-type (J:124976)
• when suspended by the tail, mice do not show limb clasping, but limbs hang limply, and never are splayed as in wild-type (J:124976)
• eventually, animals cannot support themselves and lay on their sides (J:124976)
• eventually, animals cannot support themselves and lay on their sides (J:124976)
• in affected animals, knuckle-walking progressing to dragging of the hindlimbs is observed (J:124976)
• in affected animals, knuckle-walking progressing to dragging of the hindlimbs is observed (J:124976)
• at 17-18 months, mice show a shorter fore- and hindstride length (J:124976)
• at 17-18 months, mice show a shorter fore- and hindstride length (J:124976)

nervous system
• marked gliosis is seen in affected mice, with none in controls (J:124976)
• marked gliosis is seen in affected mice, with none in controls (J:124976)
• sciatic nerves of affected animals show much greater damage and loss of axonal material (J:124976)
• sciatic nerves of affected animals show much greater damage and loss of axonal material (J:124976)
• presence of inclusion bodies (structureless smooth areas) is detected in spinal cords of some affected animals (J:124976)
• presence of inclusion bodies (structureless smooth areas) is detected in spinal cords of some affected animals (J:124976)
• axons in dorsal and ventral roots in the spinal cord show heavy expression of SNCA compared to wild-type (J:124976)
• axons in dorsal and ventral roots in the spinal cord show heavy expression of SNCA compared to wild-type (J:124976)
• in 19 month-old mice, more ventral root axons display empty sheaths or diminished, compressed contents than wild-type ventral roots (J:124976)
• in 19 month-old mice, more ventral root axons display empty sheaths or diminished, compressed contents than wild-type ventral roots (J:124976)
• perinuclear lipid deposits are observed in the cytoplasm of some motor neurons (J:124976)
• increased lysosomal activity is detected in spinal cord (J:124976)
• in thoracic ventral horns of affected animals, accumulation of Lamp1-positive structures is seen in many motor neuron cell bodies, along with occasional large vacuoles (J:124976)
• perinuclear lipid deposits are observed in the cytoplasm of some motor neurons (J:124976)
• increased lysosomal activity is detected in spinal cord (J:124976)
• in thoracic ventral horns of affected animals, accumulation of Lamp1-positive structures is seen in many motor neuron cell bodies, along with occasional large vacuoles (J:124976)
• some degenerating axons are observed within intact myelin sheaths in the spinal cord (J:124976)
• some degenerating axons are observed within intact myelin sheaths in the spinal cord (J:124976)

endocrine/exocrine glands
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)

skeleton

reproductive system
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)

renal/urinary system
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)

integument
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)
• many animals' deaths are due to abscessed preputial gland cysts (J:124976)




Genotype
MGI:3723310
tg3
Allelic
Composition
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-SNCA*A53T)AAub mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice show increased survival relative to SNCA-null transgenic animals, but survival is reduced relative to wild-type or SNCA-null mice (J:124976)
• mice show increased survival relative to SNCA-null transgenic animals, but survival is reduced relative to wild-type or SNCA-null mice (J:124976)




Genotype
MGI:3723272
tg4
Allelic
Composition
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-SNCA*A53T)AAub mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• up to 4 months of age, mutants perform better than controls on the accelerating rotating rod, but beyond 4 months, display progressive difficulties maintaining balance (J:86222)
• up to 4 months of age, mutants perform better than controls on the accelerating rotating rod, but beyond 4 months, display progressive difficulties maintaining balance (J:86222)
• grip strength of forelimbs is significantly impaired (67 ponds) relative to controls (125 ponds) (J:86222)
• grip strength of forelimbs is significantly impaired (67 ponds) relative to controls (125 ponds) (J:86222)
• grip strength of forelimbs is significantly impaired (67 ponds) relative to controls (125 ponds) (J:86222)
• grip strength of forelimbs is significantly impaired (67 ponds) relative to controls (125 ponds) (J:86222)
• progressive reduction in rearing behavior is observed in animals at 6, 18, and 24 months of age, with notably decreased activity apparent at 3 months of age (J:86222)
• progressive reduction in rearing behavior is observed in animals at 6, 18, and 24 months of age, with notably decreased activity apparent at 3 months of age (J:86222)
• step length of transgenic animals is reduced relative to wild-type (1.9 cm vs 2.25 cm in wild-type) (J:86222)
• step length of transgenic animals is reduced relative to wild-type (1.9 cm vs 2.25 cm in wild-type) (J:86222)

nervous system
• signs such as ballooning and kinky, tortuous, or corkscrew shapes of neurites are observed (J:86222)
• signs such as ballooning and kinky, tortuous, or corkscrew shapes of neurites are observed (J:86222)
• accumulation of human alpha-synuclein is seen in nerve terminals and cell bodies in the dorsal motor nucleus of the vagus nerve and in axon terminals innervating the gastric myenteric plexus, although accumulation is diffuse and does not show Lewy body-like appearance (J:185489)
• accumulation of human alpha-synuclein is seen in nerve terminals and cell bodies in the dorsal motor nucleus of the vagus nerve and in axon terminals innervating the gastric myenteric plexus, although accumulation is diffuse and does not show Lewy body-like appearance (J:185489)
• signs such as ballooning and kinky, tortuous, or corkscrew shapes of neurites are observed (J:86222)
• at 7 months of age, such abnormalities are seen only occasionally in the neocortex and hippocampus, but are frequently seen in a dense network of neurites in the olfactory bulb (J:86222)
• signs such as ballooning and kinky, tortuous, or corkscrew shapes of neurites are observed (J:86222)
• at 7 months of age, such abnormalities are seen only occasionally in the neocortex and hippocampus, but are frequently seen in a dense network of neurites in the olfactory bulb (J:86222)
• corticostriatal long-term depression (LTD) is absent in old, but not young, mutants (J:181820)
• dopamine does not restore LTD in old mice, however, zaprinast, an inhibitor of phosphodiesterases, restores LTD (J:181820)
• mice, however, do not exhibit age-related differences in striatal excitability (J:181820)
• corticostriatal long-term depression (LTD) is absent in old, but not young, mutants (J:181820)
• dopamine does not restore LTD in old mice, however, zaprinast, an inhibitor of phosphodiesterases, restores LTD (J:181820)
• mice, however, do not exhibit age-related differences in striatal excitability (J:181820)

mortality/aging
• increased mortality rate in the first 180 days as compared to wild-type controls (J:214065)
• increased mortality rate in the first 180 days as compared to wild-type controls (J:214065)

digestive/alimentary system
• stool frequency is normal at 2 months of age but is 15%, 21%, and 40% lower at 9, 15, and 19 months of age, respectively (J:185489)
• total wet weight of stool and stool water content are lower in 19 month old mice compared to controls, however stool dry weight is no different and food intake and body weight are similar to controls (J:185489)
• stool frequency is normal at 2 months of age but is 15%, 21%, and 40% lower at 9, 15, and 19 months of age, respectively (J:185489)
• total wet weight of stool and stool water content are lower in 19 month old mice compared to controls, however stool dry weight is no different and food intake and body weight are similar to controls (J:185489)
• mice show a decline in gastric emptying with age, with twice as much residual food remaining in the stomachs of 20 month old mutants as in controls (J:185489)
• mice show a decline in gastric emptying with age, with twice as much residual food remaining in the stomachs of 20 month old mutants as in controls (J:185489)

Mouse Models of Human Disease
OMIM ID Ref(s)
Parkinson Disease 1, Autosomal Dominant; PARK1 168601 J:181820 , J:185489




Genotype
MGI:5639272
tg5
Allelic
Composition
Tg(Prnp-SNCA*A53T)AAub/?
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-SNCA*A53T)AAub mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• middle-aged (7-8 months) dopaminergic substantia nigra neurons show an approximate 100% increase in mean firing rates, prolonged action potential repolarization, and more prominent pacemaking patterns (J:216589)
• however, electrical activity of dopaminergic ventral tegmental area neurons is not altered (J:216589)
• dopaminergic substantia nigra neurons from young (3-4 months) adults already show faster in vivo firing frequencies compared to controls, with mean firing frequencies about 50% higher, however, differences in action potential repolarization are not yet apparent at 3-4 months of age (J:216589)
• the regularity of firing is lower in 3 month old dopaminergic substantia nigra neurons (J:216589)
• middle-aged (7-8 months) dopaminergic substantia nigra neurons show an approximate 100% increase in mean firing rates, prolonged action potential repolarization, and more prominent pacemaking patterns (J:216589)
• however, electrical activity of dopaminergic ventral tegmental area neurons is not altered (J:216589)
• dopaminergic substantia nigra neurons from young (3-4 months) adults already show faster in vivo firing frequencies compared to controls, with mean firing frequencies about 50% higher, however, differences in action potential repolarization are not yet apparent at 3-4 months of age (J:216589)
• the regularity of firing is lower in 3 month old dopaminergic substantia nigra neurons (J:216589)
• middle-aged (7-8 months) dopaminergic substantia nigra neurons show an approximate 100% increase in mean firing rates, prolonged action potential repolarization, and more prominent pacemaking patterns, with faster firing frequencies seen already at 3-4 months of age (J:216589)
• middle-aged (7-8 months) dopaminergic substantia nigra neurons show an approximate 100% increase in mean firing rates, prolonged action potential repolarization, and more prominent pacemaking patterns, with faster firing frequencies seen already at 3-4 months of age (J:216589)
• approximate 40% reduction of maximal A-type Kv4.3 potassium conductances in dopaminergic substantia nigra neurons of middle-aged mice (J:216589)
• intracellular dialysis of the reducing agent glutathione rescues the A-type K channel dysfunction (J:216589)
• approximate 40% reduction of maximal A-type Kv4.3 potassium conductances in dopaminergic substantia nigra neurons of middle-aged mice (J:216589)
• intracellular dialysis of the reducing agent glutathione rescues the A-type K channel dysfunction (J:216589)

Mouse Models of Human Disease
OMIM ID Ref(s)
Parkinson Disease 1, Autosomal Dominant; PARK1 168601 J:216589





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory